null

Anti-BTLA (Tifcemalimab biosimilar) mAb (HDBS0742)

SKU:
HDBS0742
Antibody Type:
Biosimilar Reference Antibody
Applications:
IHC
FC
Drug Development
Pharmacokinetics
Disease Area:
Cancer
Size:
100 μg
Target:
BTLA
Isotype:
IgG4
Host Species:
Whole mAb
Reactivity:
Human
$515

Description

system_update_altDatasheetsystem_update_altMSDS
Product Name:Anti-BTLA (Tifcemalimab biosimilar) mAb
SKU:HDBS0742
Size:100 μg
Target:BTLA
Common Name:Icatolimab;JS-004;JS004;JS 004;JS-4;JS4;JS 4;TAB-004;TAB004;TAB 004;TAB-4;TAB4;TAB 4
Isotype:IgG4
Host Species:Whole mAb
Reactivity:Human
Synonyms:BTLA;BTLA1;CD272
Conjugate:Unconjugated

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Uniprot:Q7Z6A9
Formulation & Reconstitution:Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.
Usage:Research use only
Storage & Shipping:Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Related Products